The CRC-bearing rats treated with PGPs-NE exhibited normalized metalloproteinase activity, stable biomarkers for cancer and inflammation, improved liver function, increased antioxidant levels, reduced levels of fragmented DNA, and PCNA expression. Here, PCNA is linked to colorectal carcinoma.